StockData
LB Pharmaceuticals Inc logo

LB Pharmaceuticals Inc (LBRX) stock

LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$40.30−2.69 (-6.26%)

Close on Nov 17, 2026Market cap $1.30BP/E –Yield –

LB Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

LB Pharmaceuticals's enterprise value was $957.43M on Nov 11, 2026, against $135.57M a year earlier.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$957.43M+285.0%
2025Dec 31, 2025$248.66M–

More LB Pharmaceuticals figures

See a number that looks wrong?